State OR
Clinical Trials in Oregon
Recruiting clinical trials with at least one study location in Oregon. Data updated daily from ClinicalTrials.gov.
Top Conditions in Oregon
Malignant Solid Neoplasm (5)Advanced Solid Tumor (5)Prostate Cancer (4)Acute Myeloid Leukemia (4)Parkinson Disease (4)Myeloproliferative Neoplasm (3)Hematopoietic and Lymphatic System Neoplasm (3)Acute Lymphoblastic Leukemia (3)Atopic Dermatitis (3)Breast Cancer (3)Acute Respiratory Distress Syndrome (3)NSCLC (Non-small Cell Lung Cancer) (3)
NCT06837662 N/A
Recruiting
The MOUD Plus Pilot: Counseling and Peer Support to Support Retention for Medica...
Condition
Opioid Dependence
Enrollment
70 pts
Location
United States
Sponsor
Oregon Health and Science Univ
NCT04828798 N/A
Recruiting
Directional Versus Nondirectional DBS for ET
Condition
Essential Tremor
Enrollment
24 pts
Location
United States
Sponsor
Oregon Health and Science Univ
NCT05768932 Phase 1
Recruiting
BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute M...
Condition
Advanced Solid Tumor
Enrollment
260 pts
Location
United States, South Korea
Sponsor
SillaJen, Inc.
NCT05275972 Phase 3
Recruiting
Descemet Endothelial Thickness Comparison Trial II
Condition
Fuchs
Enrollment
60 pts
Location
United States
Sponsor
Stanford University
NCT07283939 N/A
Recruiting
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned...
Condition
Ampulla of Vater Carcinoma
Enrollment
420 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT06819007 Phase 3
Recruiting
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy ...
Condition
Ovarian Cancer
Enrollment
582 pts
Location
United States, Australia, Austria
Sponsor
Daiichi Sankyo
NCT05633654 Phase 3
Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physic...
Condition
Triple Negative Breast Cancer
Enrollment
1,514 pts
Location
United States, Australia, France
Sponsor
Gilead Sciences
NCT05256940 N/A
Recruiting
Motivational Interviewing to Address Suicidal Ideation for Veterans at High Risk...
Condition
Suicide, Attempted
Enrollment
470 pts
Location
United States
Sponsor
VA Office of Research and Deve
NCT06088290 Phase 3
Recruiting
Study of Lurbinectedin in Combination With Doxorubicin Versus Doxorubicin Alone ...
Condition
Leiomyosarcoma
Enrollment
450 pts
Location
United States, Austria, Belgium
Sponsor
PharmaMar
NCT04900298 N/A
Recruiting
Reducing Intraoperative ESKAPE Transmission Through Use of a Personal Hand Hygie...
Condition
Surgical Wound Infection
Enrollment
40 pts
Location
United States
Sponsor
Oregon Health and Science Univ
NCT04634552 Phase 2
Recruiting
A Study of Talquetamab in Participants With Relapsed or Refractory Multiple Myel...
Condition
Hematological Malignancies
Enrollment
510 pts
Location
United States, Belgium, China
Sponsor
Janssen Research & Development
NCT03723928 N/A
Recruiting
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Re...
Condition
Anatomic Stage IV Breast Cancer AJCC v8
Enrollment
739 pts
Location
United States, Guam, Puerto Rico
Sponsor
SWOG Cancer Research Network
NCT02986984 N/A
Recruiting
Transformative Research in Diabetic Nephropathy
Condition
Diabetic Nephropathies
Enrollment
400 pts
Location
United States
Sponsor
University of Pennsylvania
NCT06655896 Phase 2
Recruiting
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Diffuse Cu...
Condition
Scleroderma, Diffuse
Enrollment
96 pts
Location
United States, Australia, Austria
Sponsor
Novartis Pharmaceuticals
NCT03511118 N/A
Recruiting
Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breast...
Condition
Lactating Women on Select DOI
Enrollment
1,600 pts
Location
United States, Canada
Sponsor
Duke University
NCT05875168 Phase 1, Phase 2
Recruiting
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
540 pts
Location
United States, Belgium, Canada
Sponsor
Daiichi Sankyo
NCT06872125 Phase 3
Recruiting
A Double-blind Study Evaluating the Efficacy, Safety, and Tolerability of Zorevu...
Condition
Dravet Syndrome
Enrollment
170 pts
Location
United States, Japan, United Kingdom
Sponsor
Stoke Therapeutics, Inc
NCT05454007 N/A
Recruiting
Tracking Post-stroke Walking Improvements From the Clinic Into the Home
Condition
Stroke
Enrollment
25 pts
Location
United States
Sponsor
Western University of Health S
NCT06389136 Phase 3
Recruiting
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Der...
Condition
Atopic Dermatitis
Enrollment
200 pts
Location
United States, Canada, Colombia
Sponsor
AbbVie
NCT06475989 Phase 3
Recruiting
Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer
Condition
Refractory Differentiated Thyroid Gland Carcinoma
Enrollment
264 pts
Location
United States
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT05079282 Phase 1
Recruiting
Study of ONO-4685 in Patients With Relapsed or Refractory T Cell Lymphoma
Condition
Relapsed or Refractory T Cell Lymphoma
Enrollment
217 pts
Location
United States
Sponsor
Ono Pharmaceutical Co. Ltd
NCT06498635 Phase 3
Recruiting
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After ...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
306 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05881460 N/A
Recruiting
Vibrotactile Coordinated Reset: a Non-invasive Treatment for Parkinson's Disease...
Condition
Parkinson Disease
Enrollment
30 pts
Location
United States
Sponsor
Synergic Medical Technologies,
NCT06384742 N/A
Recruiting
Shift Worker Intervention for Sleep Health
Condition
Shift Work Type Circadian Rhythm Sleep Disorder
Enrollment
60 pts
Location
United States
Sponsor
Oregon State University
NCT03435796 Phase 2, Phase 3
Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Condition
Neoplasms
Enrollment
1,541 pts
Location
United States, Australia, Austria
Sponsor
Celgene